Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Grey Wolf Animal Health Corp ( (TSE:WOLF) ) has shared an update.
Grey Wolf Animal Health Corp reported a significant increase in its financial performance for the third quarter of 2025, with revenue rising by 35.3% to $9.3 million and gross profit increasing by 40.2% to $4.9 million. The growth was driven by the pharmacy business, which saw a 52.4% increase in sales due to the acquisition of the Compounding Pharmacy of Manitoba and organic growth. Despite some softness in veterinary clinic visits, the animal health segment also experienced growth, contributing to a 56.4% rise in adjusted EBITDA, reflecting improved operational efficiency and market positioning.
More about Grey Wolf Animal Health Corp
Grey Wolf Animal Health Corp is a Canadian diversified health company focusing on the pharmacy and animal health sectors. The company offers compounded products and gastrointestinal and behavior products, with a market focus on veterinary clinics and pharmacies.
Average Trading Volume: 90,754
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$44.79M
Learn more about WOLF stock on TipRanks’ Stock Analysis page.